Bezuclastinib Tablets (Formulation A)
CGT9486-21-202
Phase 2 small_molecule active
Quick answer
Bezuclastinib Tablets (Formulation A) for SSM is a Phase 2 program (small_molecule) at Cogent Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cogent Biosciences
- Indication
- SSM
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active